Polymorphisms of cholesterol 24-hydroxylase (CYP46A1) gene were protective against Alzheimer's disease in Chinese population

被引：0
|
作者：
Ling, S [1 ]
机构：
[1] Chinese Univ Hong Kong, Fac Med, Dept Psychiat, Shatin, Hong Kong, Peoples R China
来源：
INTERNATIONAL PSYCHOGERIATRICS | 2005年 / 17卷
关键词：
D O I：
暂无
中图分类号：
B849 [应用心理学];
学科分类号：
040203 ;
摘要：
引用
收藏
页码：3 / 4
页数：2
相关论文
共 50 条
  • [31] The IVS3+43C→T polymorphism in the cholesterol 24-hydroxylase gene is associated with Alzheimer's disease.
    Koelsch, H
    Ptok, U
    Schmitz, S
    Schulte, A
    Jessen, F
    Heun, R
    Luetjohann, D
    von Bergmann, K
    Rao, ML
    Maier, W
    NEUROBIOLOGY OF AGING, 2002, 23 (01) : S328 - S328
  • [32] Investigating the Effects of Brain Cholesterol Metabolism Using CYP46A1 Gene Therapy in Subjects with Huntington's Disease
    Schultz, Meredith
    Durr, Alexandra
    Karachi, Carine
    O'Callaghan, Michael
    Alves, Sandro
    Lamontagne, Alain
    Hurmic, Hortense
    Cartier, Nathalie
    NEUROLOGY, 2023, 100 (17)
  • [33] AAV Gene Therapy with Cholesterol 24-Hydroxylase for Alzheimer Disease: In Vivo Consequences on Amyloid and Tau Components of the Pathology
    Gautier, Benoit
    Burlot, Marie Anne
    Blum, David
    Hudry, Eloise
    Ayciriex, Sophie
    Troquier, L.
    Zommer, N.
    Caillerez, R.
    Auzeil, Vincent
    Braudeau, Jerome
    Laprevote, Olivier
    Pradier, Laurent
    Aubourg, Patrick
    Buee, Luc
    Cartier, Nathalie
    MOLECULAR THERAPY, 2012, 20 : S30 - S31
  • [34] AAV-mediated CYP46A1 gene therapy for Huntington's disease
    Cartier, N.
    Alves, S.
    Christaller, W.
    Subashi, E.
    Kacher, R.
    Lamaziere, A.
    Despres, G.
    Saudou, F.
    Caboche, J.
    Betuing, S.
    HUMAN GENE THERAPY, 2017, 28 (12) : A3 - A3
  • [35] CYP46A1 Functional Promoter Haplotypes Decipher Genetic Susceptibility to Alzheimer's Disease
    Li, Yan
    Chu, Leung-Wing
    Wang, Binbin
    Yik, Ping-Yiu
    Huriletemuer
    Jin, Dong-Yan
    Ma, Xu
    Song, You-Qiang
    JOURNAL OF ALZHEIMERS DISEASE, 2010, 21 (04) : 1311 - 1323
  • [36] Polymorphism in the cholesterol 24S-hydroxylase gene is associated with Alzheimer's disease
    Kölsch, H
    Lütjohann, D
    Ludwig, M
    Schulte, A
    Ptok, U
    Jessen, F
    von Bergmann, K
    Rao, ML
    Maier, W
    Heun, R
    MOLECULAR PSYCHIATRY, 2002, 7 (08) : 899 - 902
  • [37] Polymorphism in the cholesterol 24S-hydroxylase gene is associated with Alzheimer's disease
    H Kölsch
    D Lütjohann
    M Ludwig
    A Schulte
    U Ptok
    F Jessen
    K von Bergmann
    M L Rao
    W Maier
    R Heun
    Molecular Psychiatry, 2002, 7 : 899 - 902
  • [38] CYP46A1 activation by low-dose efavirenz enhances brain cholesterol metabolism in subjects with early Alzheimer’s disease
    Alan J. Lerner
    Steven E. Arnold
    Erin Maxfield
    Aaron Koenig
    Maria E. Toth
    Brooke Fortin
    Natalia Mast
    Bianca A. Trombetta
    John Denker
    Andrew A. Pieper
    Curtis Tatsuoka
    Sangeetha Raghupathy
    Irina A. Pikuleva
    Alzheimer's Research & Therapy, 14
  • [39] CYP46A1 activation by low-dose efavirenz enhances brain cholesterol metabolism in subjects with early Alzheimer's disease
    Lerner, Alan J.
    Arnold, Steven E.
    Maxfield, Erin
    Koenig, Aaron
    Toth, Maria E.
    Fortin, Brooke
    Mast, Natalia
    Trombetta, Bianca A.
    Denker, John
    Pieper, Andrew A.
    Tatsuoka, Curtis
    Raghupathy, Sangeetha
    Pikuleva, Irina A.
    ALZHEIMERS RESEARCH & THERAPY, 2022, 14 (01)
  • [40] CYP46A1, the rate-limiting enzyme for cholesterol degradation, is neuroprotective in Huntington's disease
    Boussicault, Lydie
    Alves, Sandro
    Lamaziere, Antonin
    Planques, Anabelle
    Heck, Nicolas
    Moumne, Lara
    Despres, Gaetan
    Bolte, Susanne
    Hu, Amelie
    Pages, Christiane
    Galvan, Laurie
    Piguet, Francoise
    Aubourg, Patrick
    Cartier, Nathalie
    Caboche, Jocelyne
    Betuing, Sandrine
    BRAIN, 2016, 139 : 953 - 970
12345